Melanoma gene discovery may improve diagnosis and treatment
10 October, 2011 by Tim DeanFour new genes associated with melanoma susceptibility have been uncovered, revealing insights into skin cancer and raising the prospect of improved diagnosis and treatment.
Feature: Collapsing breast cancer’s niche
05 October, 2011 by Fiona WylieTwo Sydney researchers coming from entirely different backgrounds have teamed up to find out how the hedgehog pathway is being hijacked by breast cancer calls – with a potential win-win result for patients.
Vegenics files for IND for anti-cancer drug
04 October, 2011 by Staff WritersCircadian subsidiary, Vegenics, has submitted investigational new drug (IND) application for anti-cancer drug VGX-100.
Fat’s proteomic fingerprint sheds light on Type 2 diabetes
30 September, 2011 by Staff WritersA proteomic analysis of fat cells has lent insight into the role of insulin, providing potential targets for future Type 2 diabetes treatments.
Insight into how chemotherapy causes low platelets
26 September, 2011 by Staff WritersNew research uncovering how chemotherapy reduces platelet count in cancer patients may lead to new strategies to prevent chemotherapy-induced thrombocytopenia.
Gene ‘switch’ discovered for Type 2 diabetes
23 September, 2011 by Staff WritersA single gene has been found to control the onset of Type 2 diabetes after eating a high-fat diet, lending hope that a new treatment might be found.
Feature: Dosing the poison
21 September, 2011 by Graeme O'NeillAssociate Professor Martina Stenzel is developing polymer nanoparticles that can help target the effects of chemotherapy drugs on tumours while sparing healthy cells.
Genetic link between schizophrenia and bi-polar discovered
19 September, 2011 by Tim DeanTwo landmark genetic studies have found 11 regions that are associated with both diseases, suggesting some common underlying causes.
Feature: Going rogue
06 September, 2011 by Fiona WylieTony Purcell is using the latest in immunoproteomics technology to detect, monitor and hopefully eliminate rogue T cells that cause autoimmune disease with minimal collateral damage to the good guys.
Trial of xenotransplantation treatment for diabetes kicks off in Argentina
22 August, 2011 by Staff WritersLiving Cell Technologies has begun a trial of its xenotransplantation therapy for the treatment of Type 1 diabetes in Argentina.
Tiny genetic error responsible for hereditary cancer
17 August, 2011 by Tim DeanA single hereditary error in DNA can cause a key anti-cancer gene to switch off, giving a greater risk of developing cancer.
Genetic study hones in on causes of MS
11 August, 2011 by Tim Dean29 genes influencing multiple sclerosis (MS) have been uncovered in an international GWAS study, showing the immune system and T cells play a crucial role in the disease.
New molecules offer hope for treating HIV and cancer
05 August, 2011 by Tim DeanThe discovery of two molecules that block endocytosis opens up the possibility of selectively preventing viruses like HIV from infecting cells and for halting the growth of cancers.
Sydney and UK researchers gang up on malaria
22 July, 2011 by Tim DeanResearchers from Sydney and the UK are partnering to understand why malaria can be fatal to some but milder in others.
Combined therapy offers promise for aggressive breast cancers
19 July, 2011 by Staff WritersA combination of a new anti-cancer drug with conventional chemotherapy offers improved results for aggressive ‘triple negative’ breast cancers.
